- Thyroid
- Cholestyramine Use for Rapid Reversion to Euthyroid States in Patients with Thyrotoxicosis
-
Jeonghoon Ha, Kwanhoon Jo, Borami Kang, Min-Hee Kim, Dong-Jun Lim
-
Endocrinol Metab. 2016;31(3):476-479. Published online July 26, 2016
-
DOI: https://doi.org/10.3803/EnM.2016.31.3.476
-
-
5,584
View
-
59
Download
-
6
Web of Science
-
8
Crossref
-
Abstract
PDF PubReader
Cholestyramine (CS) is an ion exchange resin, which binds to iodothyronines and would lower serum thyroid hormone level. The use of CS added to conventional antithyroid drugs to control thyrotoxicosis has been applied since 1980's, and several studies indicate that using CS in combination with methimazole (MZ) produces a more rapid decline in serum thyroid hormones than with only MZ treatment. Our recent retrospective review of five patients taking high dose MZ and CS, compared to age-, gender-, initial free thyroxine (T4) level-, and MZ dose-matched 12 patients with MZ use only, showed more rapid decline of both free T4 and triiodothyronine levels without more adverse events. CS could be safely applicable short-term adjunctive therapy when first-line antithyroid medications are not enough to adequately control severe thyrotoxicosis or side effects of antithyroid drug would be of great concern.
-
Citations
Citations to this article as recorded by 
- Management Aspects of Medical Therapy in Graves Disease
Rutu Shah, Samantha E. Adamson, Sina Jasim Endocrine Practice.2024;[Epub] CrossRef - Therapeutic plasma exchange for Graves’ disease in pregnancy
Matthew Lumchee, Mimi Yue, Josephine Laurie, Adam Morton Obstetric Medicine.2023; 16(2): 126. CrossRef - Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: a case report and review of the literature
Fatima Alsalama, Salma Alzaabi, Cynthia Salloum, Marilyne Abi Younes, Feras Bader, Hussam Ghalib, Bassam Atallah Drugs & Therapy Perspectives.2023; 39(4): 147. CrossRef - Amiodarone Induced Thyrotoxicosis and Treatment Complications in a Man With Cyanotic Congenital Heart Disease: A Case Report
Marvin Wei Jie Chua, Shao Feng Mok Frontiers in Cardiovascular Medicine.2020;[Epub] CrossRef - Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves’ disease
Patrícia Novais Rabelo, Paula Novais Rabelo, Allyne Fernanda de Paula, Samuel Amanso da Conceição, Daniela Pultrini Pereira de Oliveira Viggiano, Daniela Espíndola Antunes, Estela Muszkat Jatene, Sílvia Leda França Moura de Paula, Monike Lourenço Dias, Ma Revista da Associação Médica Brasileira.2019; 65(6): 755. CrossRef - Notes on Trauma-Related Thyroid Storm in the Emergency Department
Adam Morton The Journal of Emergency Medicine.2018; 54(2): e35. CrossRef - Risk of embryopathies with use of antithyroidal medications
Stine L. Andersen Current Opinion in Endocrinology, Diabetes & Obesity.2017; 24(5): 364. CrossRef - Thiamazole
Reactions Weekly.2017; 1644(1): 291. CrossRef
|